Regucalcin as a potential biomarker for metabolic and neuronal diseases.

about

Proteomic Characterization of Primary Mouse Hepatocytes in Collagen Monolayer and Sandwich Culture.

P2860

Q48307809-AC1070E3-8171-47FB-8459-EDA8317D2777

P2860

Regucalcin as a potential biomarker for metabolic and neuronal diseases.

Item

http://www.wikidata.org/entity/Q38193747

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Regucalcin as a potential biomarker for metabolic and neuronal diseases.

@en

type

Item

label

Regucalcin as a potential biomarker for metabolic and neuronal diseases.

@en

prefLabel

Regucalcin as a potential biomarker for metabolic and neuronal diseases.

@en

P1476

Regucalcin as a potential biomarker for metabolic and neuronal diseases.

@en

P2093

Masayoshi Yamaguchi

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated, functionally annotated gene map of the DXS8026-ELK1 interval on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders

Oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney. A comparative study of cephaloridine and cephaloglycin

Overexpression of regucalcin enhances glucose utilization and lipid production in cloned rat hepatoma H4-II-E cells: Involvement of insulin resistance

Expression of Ca(2+)-binding protein regucalcin in rat brain neurons: inhibitory effect on protein phosphatase activity

Purification of calcium binding substance from soluble fraction of normal rat liver

Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-alpha: analysis of proteins involved in insulin resistance.

Specific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissue.

Inhibitory role of regucalcin in the regulation of Ca2+ dependent protein kinases activity in rat brain neurons.

SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span.

Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay.

P2888

s11010-014-1998-2

P304

157-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-014-1998-2

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

391

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260559222

http://www.w3.org/2001/XMLSchema#string

P6179

1040767218

http://www.w3.org/2001/XMLSchema#string

P698

24599745

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Regucalcin as a potential biomarker for metabolic and neuronal diseases.

about

P2860

P2860

Regucalcin as a potential biomarker for metabolic and neuronal diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921